STTK Valuation

Shattuck Labs Inc

Add to Watchlist

Advanced Chart

2.450

+0.17(7.456%)1D

Overview
Forecast
Valuation
Earnings

STTK Relative Valuation

STTK's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, STTK is overvalued; if below, it's undervalued.

Historical Valuation

Shattuck Labs Inc (STTK) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -5.65. The fair price of Shattuck Labs Inc (STTK) is between to according to relative valuation methord.

Relative Value

Fair Zone

Current Price：2.45

Fair

-4.69

Trailing

Forward

-0.99

EV/EBITDA

Shattuck Labs Inc. (STTK) has a current EV/EBITDA of -0.99. The 5-year average EV/EBITDA is -2.74. The thresholds are as follows: Strongly Undervalued below -15.44, Undervalued between -15.44 and -9.09, Fairly Valued between 3.62 and -9.09, Overvalued between 3.62 and 9.97, and Strongly Overvalued above 9.97. The current Forward EV/EBITDA of -0.99 falls within the Historic Trend Line -Fairly Valued range.

-1.23

EV/EBIT

Shattuck Labs Inc. (STTK) has a current EV/EBIT of -1.23. The 5-year average EV/EBIT is -3.51. The thresholds are as follows: Strongly Undervalued below -17.94, Undervalued between -17.94 and -10.73, Fairly Valued between 3.70 and -10.73, Overvalued between 3.70 and 10.92, and Strongly Overvalued above 10.92. The current Forward EV/EBIT of -1.23 falls within the Historic Trend Line -Fairly Valued range.

0.00

Shattuck Labs Inc. (STTK) has a current PS of 0.00. The 5-year average PS is 437.96. The thresholds are as follows: Strongly Undervalued below -1644.60, Undervalued between -1644.60 and -603.32, Fairly Valued between 1479.24 and -603.32, Overvalued between 1479.24 and 2520.51, and Strongly Overvalued above 2520.51. The current Forward PS of 0.00 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/OCF

Shattuck Labs Inc. (STTK) has a current P/OCF of 0.00. The 5-year average P/OCF is -4.76. The thresholds are as follows: Strongly Undervalued below -20.39, Undervalued between -20.39 and -12.58, Fairly Valued between 3.05 and -12.58, Overvalued between 3.05 and 10.87, and Strongly Overvalued above 10.87. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/FCF

Shattuck Labs Inc. (STTK) has a current P/FCF of 0.00. The 5-year average P/FCF is -5.20. The thresholds are as follows: Strongly Undervalued below -19.71, Undervalued between -19.71 and -12.45, Fairly Valued between 2.06 and -12.45, Overvalued between 2.06 and 9.32, and Strongly Overvalued above 9.32. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

Shattuck Labs Inc (STTK) has a current Price-to-Book (P/B) ratio of 2.06. Compared to its 3-year average P/B ratio of 1.19 , the current P/B ratio is approximately 73.12% higher. Relative to its 5-year average P/B ratio of 1.41, the current P/B ratio is about 46.25% higher. Shattuck Labs Inc (STTK) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -82.34%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -57.54% , the current FCF yield is about -100.00% lower.

2.06

P/B

Median3y

1.19

Median5y

1.41

-51.22

FCF Yield

Median3y

-82.34

Median5y

-57.54

Competitors Valuation Multiple

The average P/S ratio for STTK's competitors is 0.00, providing a benchmark for relative valuation. Shattuck Labs Inc Corp (STTK) exhibits a P/S ratio of 0.00, which is NaN% above the industry average. Given its robust revenue growth of -100.00%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Zentalis Pharmaceuticals Inc

Loss

109.65M

ANIX.O

Anixa Biosciences Inc

Fate Therapeutics Inc

Armata Pharmaceuticals Inc

Loss

109.41M

Performance Decomposition

Market capitalization of STTK increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of STTK in the past 1 year is driven by Unknown.